Valneva SE (VALN) Land & Improvements (2020 - 2022)
Valneva SE (VALN) posted quarterly Land & Improvements of $26.7 million for Q2 2022, down 2.08% on a QoQ basis from $27.3 million in Q4 2021.
Valneva SE (VALN) Land & Improvements (2020 - 2022) Analysis & Trends
Valneva SE (VALN) has reported Land & Improvements for 3 consecutive years, with $26.7 million the latest figure, recorded in Q2 2022.
- Quarterly Land & Improvements changed N/A year-over-year to $26.7 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $26.7 million (changed N/A YoY) and the FY2021 annual result came in at $27.3 million, down 3.23% from the prior year.
- Land & Improvements declined to $26.7 million in Q2 2022 per VALN's latest filing, from $27.3 million in the prior quarter.
- Over the last five years, Land & Improvements for VALN reached as high as $28.2 million in Q4 2020 and fell as low as $26.7 million in Q2 2022.
- A 3-year average of $27.4 million and a median of $27.3 million in 2021 frame the typical range for Land & Improvements.
- The largest YoY upside for Land & Improvements was 3.23% in 2021 against a maximum downside of 3.23% in 2021.
- Year by year, Land & Improvements stood at $28.2 million in 2020, then declined by 3.23% to $27.3 million in 2021, then dropped by 2.08% to $26.7 million in 2022.
- According to Business Quant data, Land & Improvements over the past three periods registered $26.7 million, $27.3 million, and $28.2 million for Q2 2022, Q4 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 26.74 Mn |
| Dec 31, 2021 | 27.31 Mn |
| Dec 31, 2020 | 28.22 Mn |